Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancer

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 4015-4018

  Vigani, A ^a   Pensa, F ^a   Vaira, F ^a   Bancalari, L ^a   Cordani, S ^a   Maggiani, R ^a   Canessa, P ^a   Pronzato, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chemotherapy dose intensity; Filgrastim; Small cell lung cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HAIR LOSS; HUMAN; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUROPATHY; PAIN; PRIORITY JOURNAL; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; ETOPOSIDE; FEMALE; FILGRASTIM; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PLATELET COUNT; VINCRISTINE;

EID: 0034532162     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Intensive chemotherapy of small cell bronchogenic carcinoma
2. High dose cyclophosphamide (C) in the induction (IND) chemotherapy (CT) of small cell lung cancer (SCLC) - Minor improvements in rate of remission and survival
3. A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer
4. High-dose intensity cyclophosphamide epidoxorubicin, vincristine and prednisone by shortened intelvals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: A phase II study
5. Reporting results of cancer treatment
6. The importance of dose intensity in chemotherapy of metastatic breast cancer
7. Optimal two stage designs for phase II clinical trials
8. Dose intensity versus total dose of chemotherapy: An experimental basis
9. Impact of dose-intense chemotherapy on the development of permanent drug resistance
10. Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy. A randomised study in patients with advanced stage disease
11. Granulocyte colony stimulating factor: Prevention of chemotherapy-induced febrile neutropenia in patients with small cell lung cancer
12. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy
13. Enhanced myelotoxicity due to Granulocyte Colony-Stimulating Factor admistration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma
14. Dose-intensity meta-analysis of chemotherapy regimens in small cell carcinoma of the lung
15. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin in chemotherapy in patients with extensive stage small cell lung cancer
16. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer
17. Dose intensification (DI) with G-CSF improves survival in small cell lung cancer (SCLC): Results of a randomized trial
18. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
19. Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer. A prospective randomised study of 300 patients
20. Can cytotoxic dose intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer
21. Chemoradiotherapy with or without granulocyte-macrophage colony stimulating factor in the treatment of limited stage small-cell lung cancer. A prospective phase III randomised study of the Southwest Oncology Group
22. Adjuvant Drug Therapy for operable breast cancer
23. 5-Year results of dose intensive sequential adjuvant chemotherapy for women with high-risk node positive breast cancer: A phase II study
24. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes
25. Randomized trial comparing induction chemotherary versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer
26. Received dose-intensity: A randomized trial of weekly chemotherapy and without granulocyte colony stimulating factor in small cell lung cancer
27. High dose cyclophosphamide in small cell carcinoma of the lung
28. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell lung carcinoma of the lung: A randomized study